(Circulation. 1996;94:1283-1290.)
© 1996 American Heart Association, Inc.
Articles |
the Departments of Surgery, Biophysics (A.P.G.H.), and Pathology (M.J.A.P.D.), Cardiovascular Research Institute Maastricht, the Netherlands.
Correspondence to L. Hofstra, MD, Department of Surgery, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands.
Background Vascular interventions are often complicated by the development of intimal thickening, leading to stenosis. Cellular proliferation is a key event in stenosis formation in animals, but the role of cell proliferation in intimal thickening in humans is still unclear. Furthermore, the relation between proliferation in human stenotic lesions and flow parameters has not been established.
Methods and Results We studied the proliferation patterns of 35 anatomically intact human stenotic lesions derived from either peripheral bypasses (normal flow) or hemodialysis AV fistulas (high flow) with the use of Ki-67, a cell proliferation marker. Local flow parameters were assessed with ultrasound. Proliferation patterns were similar in AV fistula and bypass stenoses. In the intima, proliferation was highest in the area just below the endothelium (AV fistulas, 3.6%; bypasses, 3.5%; P=NS). In adjacent nonstenotic vessel segments that were used as controls, proliferation rate in the intima was 0.3%. Double-labeling studies revealed that subendothelial-intimal proliferation consisted mainly (90%) of vascular smooth muscle cells, whereas proliferation in the other layers of the vessel wall also consisted of endothelial cells and macrophages. Blood flow velocity was negatively correlated with subendothelial-intimal proliferation (r=-.61, P<.05). The endothelial cell coverage of the lumen was positively correlated with proliferation (r=.85, P<.01).
Conclusions These data suggest enhanced cellular proliferation in human stenotic tissue derived from AV fistulas and peripheral bypass grafts. Furthermore, high proliferation rates seem to be associated with endothelial cell coverage of the lumen and low local flow velocities.
Key Words: bypass grafting endothelium blood flow stenosis
This article has been cited by other articles:
![]() |
S.-C. Chen, J.-M. Chang, S.-J. Hwang, J.-C. Tsai, C.-S. Wang, H.-C. Mai, F.-H. Lin, H.-M. Su, and H.-C. Chen Significant Correlation between Ankle-Brachial Index and Vascular Access Failure in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S Dixon, G. J Beck, L. M Dember, T. A Depner, J. J Gassman, T. Greene, J. Himmelfar, L. G Hunsicker, J. S Kaufman, J. H Lawson, et al. Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial Clinical Trials, October 1, 2005; 2(5): 400 - 412. [Abstract] [PDF] |
||||
![]() |
K. A. Nath, S. K. R. Kanakiriya, J. P. Grande, A. J. Croatt, and Z. S. Katusic Increased Venous Proinflammatory Gene Expression and Intimal Hyperplasia in an Aorto-Caval Fistula Model in the Rat Am. J. Pathol., June 1, 2003; 162(6): 2079 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallenbach, H. A. Fernandez, G. Seghezzi, F. G. Baumann, S. Patel, E. A. Grossi, A. C. Galloway, and P. Mignatti A Quantitative In Vitro Model of Smooth Muscle Cell Migration Through the Arterial Wall Using the Human Amniotic Membrane Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1008 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Mehrabi, N. Serbecic, F. Tamaddon, C. Kaun, K. Huber, R. Pacher, T. Wild, G. Mall, J. Wojta, and H.-D Glogar Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease Cardiovasc Res, November 1, 2002; 56(2): 214 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.W. Broeders, P. A. Doevendans, J. G. Maessen, E. van Gorsel, M. G.A. O. Egbrink, M. J. A.P. Daemen, G. J. Tangelder, R. S. Reneman, and R. van der Zee The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 305 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. IKEGAYA, T. YAMAMOTO, A. TAKESHITA, T. WATANABE, K. YONEMURA, T. MIYAJI, K. OHISHI, M. FURUHASHI, Y. MARUYAMA, and A. HISHIDA Elevated Erythropoietin Receptor and Transforming Growth Factor-{beta}1 Expression in Stenotic Arteriovenous Fistulae Used for Hemodialysis J. Am. Soc. Nephrol., May 1, 2000; 11(5): 928 - 935. [Abstract] [Full Text] |
||||
![]() |
S. Sivanesan, T. How, and A. Bakran Sites of stenosis in AV fistulae for haemodialysis access Nephrol. Dial. Transplant., January 1, 1999; 14(1): 118 - 120. [Abstract] [PDF] |
||||
![]() |
Y. Zou, H. Dietrich, Y. Hu, B. Metzler, G. Wick, and Q. Xu Mouse Model of Venous Bypass Graft Arteriosclerosis Am. J. Pathol., October 1, 1998; 153(4): 1301 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pourageaud and J. G. R. De Mey Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1699 - H1706. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |